P3 Health Partners Inc. (PIII) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
P3 Health Partners Inc. (PIII) stock forecast summary
Our AI ranks P3 Health Partners Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Its market capitalization is not available, so no size classification is given. Its Current Ratio of 0.46x is the lowest of the 11 peers that report one. Its D/E Ratio of 7.16x is the highest of the 12 peers that report one.
A per-ticker accuracy statistic for PIII is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.2%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, PIII included.
Follow PIII freePIII price chart and AI forecast
How PIII ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
P3 Health Partners Inc. (PIII) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Health Services peers listed below that report each metric.
Valuation & Market
| Metric | PIII | Rank |
|---|---|---|
| EPS | $-33.38 | – |
Profitability & Margins
| Metric | PIII | Rank |
|---|---|---|
| ROE | -136.4% | 8/10 |
| ROA | -15.0% | 7/10 |
| ROIC | -55.9% | 10/11 |
| Operating Margin | -9.9% | 8/12 |
| Net Margin | -6.5% | 6/10 |
| EBT Margin | -15.1% | 8/12 |
| Tax Rate | 4.7% | – |
Financial Health
| Metric | PIII | Rank |
|---|---|---|
| Current Ratio | 0.46x | 11/11 |
| D/E Ratio | 7.16x | 1/12 |
| Financial Leverage | 9.06x | 1/12 |
| Interest Coverage | -5.2x | 9/11 |
| Working Capital | -$209M | 11/11 |
Cash Flow
| Metric | PIII | Rank |
|---|---|---|
| Operating Cash Flow | -$131M | 13/13 |
Operational Efficiency
| Metric | PIII | Rank |
|---|---|---|
| Asset Turnover | 2.30x | 1/11 |
| Fixed Assets Turnover | 594.7x | 2/10 |
Income Statement
| Metric | PIII | Rank |
|---|---|---|
| Total Revenue | $1.50B | 3/11 |
| Operating Income | -$148M | 12/13 |
| Net Income | -$98M | 9/11 |
| SG&A Expense | $117M | 7/11 |
Dividend & Shareholder Information
| Metric | PIII | Rank |
|---|---|---|
| EPS Growth | -828.3% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $179M | 27.4% of assets |
| Cash & Short-term Investments | $21M | 3.3% of assets |
| Total Liabilities | $517M | 79.0% of assets |
| Short-term Debt | $381M | 58.2% of assets |
PIII quarterly financials and insider trading
P3 Health Partners Inc. (PIII) industry peers
Companies classified under the same SEC industry code as P3 Health Partners Inc. (Services-Health Services): 13 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| PIII P3 Health Partners Inc. | ▲ | N/A |
| LFST Lifestance Health Group, Inc. | ▲ | $4.71B |
| PRVA Privia Health Group, Inc. | ▼ | $2.77B |
| WGS Genedx Holdings Corp. | ▲ | $1.94B |
| PNTG Pennant Group, Inc. | ▶ | $1.40B |
| USPH U S Physical Therapy Inc /Nv | ▶ | $1.27B |
| INNV Innovage Holding Corp. | ▲ | $1.23B |
| OMDA Omada Health, Inc. | ▲ | $1.12B |
| SRTA Strata Critical Medical, Inc. | ▲ | $394M |
| EUDA Euda Health Holdings Ltd | ▶ | $32M |
| DCGO Docgo Inc. | ▲ | $30M |
| ATPC Agape Atp Corp | ▼ | N/A |
| VSEE Vsee Health, Inc. | ▼ | N/A |
Where PIII sits on the market map
P3 Health Partners Inc. (PIII) stock news
Loading...
P3 Health Partners Inc. (PIII) stock forecast FAQ
What is the P3 Health Partners Inc. (PIII) stock forecast?
Our AI ranks P3 Health Partners Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are P3 Health Partners Inc. stock predictions?
A per-ticker accuracy statistic for PIII is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are P3 Health Partners Inc. forecasts updated?
P3 Health Partners Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are P3 Health Partners Inc.'s industry peers?
13 issuers in our coverage, PIII included, share the SEC industry code Services-Health Services. The largest are: Lifestance Health Group, Inc. (LFST), Privia Health Group, Inc. (PRVA), Genedx Holdings Corp. (WGS), Pennant Group, Inc. (PNTG), U S Physical Therapy Inc /Nv (USPH), Innovage Holding Corp. (INNV).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.